HAYWARD, Calif., Jan. 11, 2022 /PRNewswire-PRWeb/ -- College Station, TX - G-CON, the leader in prefabricated, flexible cleanroom solutions, announced today that it has been selected to supply the cleanroom infrastructure for TrueBinding, Inc. (TrueBinding), an early stage biotherapeutics development company focused on creating molecules for applications in immuno-oncology and other disease areas with unmet medical needs.
G-CON will provide the engineering design, build and delivery of prefabricated cleanroom PODs totaling a 3,000 sq. ft. footprint. The POD system will consist of four PODs for upstream/downstream processing, post viral and media/buffer prep. The design will also feature built-in corridors along with material airlocks and personnel airlocks. Each POD is designed with dedicated air handling units, a fire protection system, an integrated automation system, and process utility distribution. G-CON will commission the units after delivery as part of the overall project validation effort.
"We are thrilled to have been selected by True Binding for this project after they were referred to us by another G-CON client," stated Tim Rasmussen, Design Consultant for G-CON. "TrueBinding has an aggressive timeline and PODs are ideal for meeting such a compressed schedule, especially in high construction demand regions like the bay area. We look forward to adding this project to our portfolio."
"G-CON has been an important partner in designing and constructing the manufacturing spaces we need to produce our novel molecules. By meeting our accelerated timelines, G-CON has given us the ability to deliver life changing therapeutics to patients quicker. The team we have worked with, as well as the PODs themselves, have exceeded our expectations." Maksym Tsvetkov, Production Manager for TrueBinding.
About G-CON
G-CON is fulfilling the needs of reliable and fast deliverable capacities for the biopharmaceutical industry. G-CON provides comprehensive prefabricated and prequalified CGMP compliant cleanroom environments and platforms for uses ranging from laboratory, clinical and commercial production for a variety of therapeutic applications.
Through a well-defined customer needs driven approach to design, production, installation and qualification, G-CON provides a fully functional cleanroom product portfolio enabling reliable biocapacity planning on-time and within-budget. For more information, please visit G-CON's website at http://www.gconbio.com.
About TrueBinding, Inc.
TrueBinding Inc. is an early stage biotherapeutics development company focused on creating molecules for applications in immuno-oncology and other disease areas with unmet medical needs, such as neurological disorders and neurodegenerative diseases. TrueBinding has discovered novel, uncharacterized ligands to receptors of known checkpoint inhibitor pathways for potential therapeutic development. For more information, please visit https://www.truebinding.com/.
Media Contact
Brittany Berryman, G-CON Manufacturing, 9792047975, [email protected]
SOURCE G-CON Manufacturing
Share this article